DDO3602
DDO3602 is a PARP1 HEMTAC degrader mediated by HSP90. It exhibits significant anti-tumor activity and tumor selectivity. In MCF-7 cells, DDO3602 induces G2/M phase arrest, DNA damage, and inhibition of cell migration by degrading PARP1 (IC50= 187 nM) . It is frequently utilized in research on cancers such as breast cancer.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog